RGEN Repligen Corporation

54.59
-0.56  -1%
Previous Close 55.15
Open 55.01
Price To Book 3.95
Market Cap 2394280224
Shares 43,859,319
Volume 266,794
Short Ratio
Av. Daily Volume 507,036

SEC filingsSee all SEC filings

  1. 10-Q - Quarterly report [Sections 13 or 15(d)] 181153406
  2. 8-K - Current report 181152059
  3. 10-Q - Quarterly report [Sections 13 or 15(d)] 18987595
  4. 8-K - Current report 18986700
  5. CT ORDER - Confidential treatment order 18880257

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

CRL received June 22, 2012.
RG1068
Detection of pancreatic duct abnormalities